
A Parent's Perspective: One Family's Experience With Stem Cell Therapy for Type 1 Diabetes
A mother shares her 8-year-old son's journey with an experimental stem cell treatment and the changes she observed in his insulin needs and daily life. This is one family's story—not a clinical study.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- This account comes from a community video, not peer-reviewed research, so it reflects one family's experience rather than proven medical evidence.
- The child's insulin-to-carbohydrate ratio improved over time during treatment, meaning he needed less insulin per carbohydrate consumed.
- The mother reported changes in her son's mood and behavior after starting the treatment, which she felt was significant for their family.
- Any interest in stem cell approaches for Type 1 diabetes should be discussed with a qualified healthcare provider.
A Diagnosis Changes Everything
When Mason was diagnosed with Type 1 diabetes at age 8, his mother Megan noticed shifts in his personality and mood. The frequent insulin injections—sometimes needed every few hours—added stress to the family's daily routine. Like many parents of newly diagnosed children, Megan found herself searching for answers and exploring options beyond standard insulin therapy.
An Experimental Path
Megan learned about stem cell therapy through an online forum and connected with a provider offering this experimental approach. Her family decided to pursue treatment, beginning with baseline measurements of Mason's insulin needs.
Changes in Insulin Requirements
Over the course of treatment, Mason's insulin-to-carbohydrate ratio—the amount of carbohydrates he could eat per unit of insulin—shifted notably. He started at a ratio of 1:26, meaning he needed one unit of insulin for every 26 grams of carbohydrates. This gradually improved to 1:30, and eventually to 1:38. His mother also reported that he was able to discontinue his long-acting insulin (Lantus).
These changes happened within weeks of beginning treatment, which the family found encouraging.
Mood and Quality of Life
Beyond insulin metrics, Megan observed what felt like a meaningful shift in Mason's emotional state. Within 24 hours of starting treatment, she noticed him return to his typical positive demeanor. She reported he seemed less angry and frustrated, and that family dynamics improved. For her, even if the insulin changes had plateaued, regaining her son's personality felt like a significant win.
It's important to note: this is one family's account shared in a community video, not a clinical finding from a research study.
What This Story Does and Doesn't Tell Us
Personal stories like Mason's matter to the Type 1 diabetes community—they reflect real experiences and raise important questions. However, a single account from a video is not the same as evidence from a clinical trial. We don't know how many other families tried this treatment, what their outcomes were, or whether changes would have occurred without intervention.
If you're exploring experimental treatments for Type 1 diabetes, including stem cell therapy, speak with your diabetes care team. They can help you understand both the potential benefits and the risks, and ensure any decision aligns with your family's values and health needs.
Evidence label
Source: YouTube community video. Evidence type: Community video — lay discussion, not peer-reviewed research. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Cure ResearchStem Cell Research Offers New Hope—But Questions RemainCommunity video — lay discussion, not peer-reviewed research
- Cure ResearchWhat Science Now Knows About Beta Cell Regeneration in Type 1 DiabetesCommunity video — lay discussion, not peer-reviewed research
- Cure ResearchWhat We Know About Beta Cell Regeneration Research in DiabetesCommunity video — lay discussion, not peer-reviewed research
- Cure ResearchCan Beta Cells Recover? What Research Shows About Pancreatic Function and Type 2 DiabetesCommunity video — lay discussion, not peer-reviewed research
- Cure ResearchWhat Is the Islet Cell Act? A Guide to Proposed Changes in Transplant RegulationCommunity video — lay discussion, not peer-reviewed research
- Cure ResearchUnderstanding Beta Cell Function in Type 2 Diabetes: What Research ShowsCommunity video — lay discussion, not peer-reviewed research